Human Genome Epidemiology Literature Finder
|
Records 1 - 4 (of 4 Records) |
| Query Trace: Disease and ASAH1[original query] |
|---|
| C26-Ceramide as highly sensitive biomarker for the diagnosis of Farber Disease. Scientific reports 2017 7 7 (1): 6149. Cozma Claudia, Iura?cu Marius-Ionu?, Eichler Sabrina, Hovakimyan Marina, Brandau Oliver, Zielke Susanne, Böttcher Tobias, Giese Anne-Katrin, Lukas Jan, Rolfs Arn |
| Excessive burden of lysosomal storage disorder gene variants in Parkinson's disease. Brain : a journal of neurology 2017 Nov . Robak Laurie A, Jansen Iris E, van Rooij Jeroen, Uitterlinden André G, Kraaij Robert, Jankovic Joseph, , Heutink Peter, Shulman Joshua |
| Spinal muscular atrophy and Farber disease due to ASAH1 variants: A case report. American journal of medical genetics. Part A 2020 7 182 (10): 2369-2371. Lee Bo Hoon, Mongiovi Phillip, Levade Thierry, Marston Bethany, Mountain Joan, Ciafaloni Em |
| The interaction of ASAH1 and NGF gene involving in neurotrophin signaling pathway contributes to schizophrenia susceptibility and psychopathology. Progress in neuro-psychopharmacology & biological psychiatry 2020 6 104 110015. Su Yousong, Yang Lu, Li Zezhi, Wang Weidi, Xing Mengjuan, Fang Yu, Cheng Ying, Lin Guan Ning, Cui Dongho |
- Page last reviewed:Feb 1, 2024
- Content source: